Pancreatic Cancer Research

ResearcherKyushu UniversityActive in the last 2 years

Chikanori Tsutsumi

Matched on ORCID iD 0000-0003-0907-4666; OpenAlex author ID A5079534176. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2020: 2 papers · 2021: none · 2022: none · 2023: none · 2024: 4 papers · 2025: 2 papers

Papers 8

  1. Identification of cold tumor induction-related markers in pancreatic cancer and the clinical implication of PCDH7. Co-author DOI 10.1007/s00432-025-06095-z↗
  2. uPAR expression in M-MDSCs under high LDHA activity in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-025-29823-4↗
  3. Immature stroma and high infiltration of CD15+ cells are predictive markers of poor prognosis in different subsets of patients with pancreatic cancer. Co-author DOI 10.1111/cas.16060↗
  4. Combined Autophagy Inhibition and Dendritic Cell Recruitment Induces Antitumor Immunity and Enhances Immune Checkpoint Blockade Sensitivity in Pancreatic Cance… Co-author DOI 10.1158/0008-5472.can-24-0830↗
  5. Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-024-03178-6↗
  6. Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-024-03192-8↗
  7. Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case report. Co-author DOI 10.1186/s40792-020-00924-8↗
  8. Correction to: Long-term survival after hepatectomy for metachronous liver metastasis of pancreatic ductal adenocarcinoma: a case report. Co-author DOI 10.1186/s40792-020-01070-x↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kohei Nakata · 6 shared papers, 2024–2025 · strength 1.13
  2. Kenoki Ohuchida · 6 shared papers, 2024–2025 · strength 1.13
  3. Yoshinao Oda · 5 shared papers, 2024–2025 · strength 0.92
  4. Chika Iwamoto · 5 shared papers, 2024–2025 · strength 0.92
  5. Naoki Ikenaga · 5 shared papers, 2024–2025 · strength 0.92
  6. Toshiya Abe · 5 shared papers, 2020–2025 · strength 0.80
  7. Koki Oyama · 4 shared papers, 2024–2025 · strength 0.71
  8. Tomohiko Shinkawa · 4 shared papers, 2020–2025 · strength 0.63
  9. Yuki Mochida · 3 shared papers, 2024–2025 · strength 0.55
  10. Noboru Ideno · 3 shared papers, 2024–2025 · strength 0.53
  11. Masafumi Nakamura · 2 shared papers, 2024–2025 · strength 0.39
  12. Bo Zhang · 2 shared papers, 2024–2025 · strength 0.39
  13. Masafumi Nakamura · 2 shared papers, 2024–2025 · strength 0.37
  14. Masafumi Nakamura · 2 shared papers, 2024 · strength 0.36
  15. Hideya Onishi · 2 shared papers, 2024–2025 · strength 0.36
  16. Koji Shindo · 2 shared papers, 2024 · strength 0.35
  17. Masataka Hayashi · 2 shared papers, 2024 · strength 0.32
  18. Haizhen Luo · 2 shared papers, 2024 · strength 0.32
  19. Pingshan Zhong · 2 shared papers, 2024 · strength 0.32
  20. Kazuyoshi Nishihara · 2 shared papers, 2020 · strength 0.27
  21. Toru Nakano · 2 shared papers, 2020 · strength 0.27
  22. Shoko Noguchi · 1 shared paper, 2024 · strength 0.21
  23. Yutaka Yamada · 1 shared paper, 2024 · strength 0.21
  24. Yoshinao Oda · 1 shared paper, 2025 · strength 0.21
  25. Yusuke Mizuuchi · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.